Summarized by Masters of Longevity from Longevity Docs News.
A news piece about a consumer microbiome company expanding into therapeutics by acquiring a startup that mines plant microbes. It invites readers curious about how testing-focused firms are building test-to-treat product pipelines.
Key Takeaways
- Viome acquired Sōlaria Biō, which screens a biobank of over 5,700 plant-derived microbes using AI.
- Sōlaria Biō’s first product, Bōndia, is a combined prebiotic and probiotic targeting the gut-bone axis for adults over 35.
- A second Sōlaria Biō candidate targeting rheumatoid arthritis and healthy aging is in clinical development.
